Frontlight ResearchEarly access
What researchers published on Endometrial cancer
17,593 papers, newest first.
Showing 40 of 17,593
Underfunded, Overperforming: Endometrial cancer leads basic and translational science publications per NCI dollar.Gynecologic oncology reports
Low MATR3 Expression Is Associated with Poor Prognosis in Endometrial Carcinoma: An Integrated Immunohistochemical and Transcriptomic Analysis.International journal of molecular sciences
Sentinel Lymph Node Mapping in Endometrial Cancer: Experience from a Tertiary Referral Center in Türkiye.Journal of clinical medicine
ReviewIncidence, Prognosis, and Management of Occult Endometrial Carcinoma After Hysterectomy for Benign Disease: A Systematic Review and Meta-Analysis.Diagnostics (Basel, Switzerland)
Role of Serum HE4, Selected Clinical Features and Diagnostic Prediction Models in Differentiating Benign and Malignant Endometrial Lesions in Polish Women: A Prospective Cohort Study.Cancers
ReviewImmune Checkpoint Inhibitors: Sculpting the Landscape of Endometrial Cancer Treatment.Cancers
Eosinophil-to-Lymphocyte Ratio as a Potential Inflammatory Marker Associated with Endometrial Cancer: An Analysis of NHANES 2017-2023 and an Independent Institutional Cohort.Diagnostics (Basel, Switzerland)
Preliminary Evaluation of the Anticancer Activity of a PGK1 Small Molecule Inhibitor in Ishikawa Endometrial Cancer.International journal of molecular sciences
ReviewSentinel Lymph Node Mapping in Endometrial Cancer in the Molecular Era: Current Evidence, Clinical Controversies, and Unresolved Questions.Journal of clinical medicine
ReviewThe Molecular, Genetic, Pathological Basis and Clinical Perspectives of Endometrial Cancer: A Narrative Review.International journal of molecular sciences
Racial and Ethnic Differences in County-Level Availability of Uterine Cancer Clinical Trials.JAMA network open
Real‑World Treatment Patterns in Endometrial Cancer in the Post-Immune Checkpoint Inhibitor and Post-Platinum-Based Chemotherapy Setting in the United States.Advances in therapy
ReviewFrom collision to conversion, the molecular renaissance of uterine carcinosarcoma in the era of antibody-drug conjugates: a scoping review.Expert review of anticancer therapy
Observational studyDisulfidptosis-related lncRNAs for establishing a new prognostic model of endometrial carcinoma and drug sensitivity prediction: A retrospective observational cohort study.Medicine
Co-mutation of KRAS and ARID1A correlates with the MSI/LINE-1 hypermethylation profile in endometrial carcinoma.Neoplasia (New York, N.Y.)
Development of a urine-based DNA methylation assay for early endometrial cancer detection: a multicenter diagnostic study.BMC medicine
Author's Reply Regarding "Long-term oncological outcomes of the ROMANHY trial: impact of intrauterine manipulator during minimally invasive surgery for early-stage endometrial cancer".Journal of minimally invasive gynecology
Clinicopathologic ımpact and prognostic value of lymphovascular space ınvasion within the MMRd molecular subgroup of endometrial carcinoma.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
Is chemotherapy still needed in all patients with mismatch repair-deficient advanced or recurrent endometrial cancer?Lancet (London, England)
Meta-analysisBenign-appearing endometrial cells on Papanicolaou test in women aged 45 years or older: a retrospective study from a large academic institution and meta-analysis of comparable cohorts.American journal of clinical pathology
ReviewBEHOLD phase 3 clinical development program of mocertatug rezetecan in ovarian and endometrial cancer.Gynecologic oncology
Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a.British journal of cancer
Impact of Coexisting Adenomyosis on the Histopathological, Immunohistochemical, and Molecular Features of Endometrial Cancer and on Adjuvant Therapy Allocation: A Single-Center Retrospective Cohort Study.Obstetrics and gynecology international
Keratin 17 drives endometrial cancer aggressiveness via epithelial-mesenchymal transition: a single-cell transcriptomic and integrative bioinformatics study.Journal of cancer research and clinical oncology
Single-port robotic surgery versus laparo-endoscopic single-site surgery for the surgical staging of early-stage endometrial cancer: a sequential-period propensity-score analysis.Journal of robotic surgery
Transvaginal ultrasound-based deep learning radiomics for preoperative identification of non-endometrioid endometrial carcinoma: A multicenter study.Clinical imaging
Long-term oncologic outcomes of pulmonary metastasectomy for lung-confined recurrent endometrial cancer: a single-institution case series.AJOG global reports
Assessment of peripheral and tumor specific Tregs and Th17 cells in patients with endometrial cancer.Cancer treatment and research communications
Relationship Between Preoperative PET-CT SUVmax Values and Solid Component in Endometrioid Type Endometrial Cancer.Indian journal of surgical oncology
Practical application and exploratory prognostic assessment of the FIGO 2023 stage IA3 criteria in endometrioid endometrial cancer with concurrent ovarian tumours.International journal of clinical oncology
MRI-based deep-learning radiomics nomogram for differentiating FIGO 2023 stage I from stage II-IV endometrial cancer: a multicenter study.Insights into imaging
Myometrial invasion and tumor free distance from serosa as prognostic factors in endometrial endometrioid carcinoma.Journal of gynecologic oncology
Multiparametric MRI-based radiomics combined with deep learning for preoperative risk stratification of endometrial carcinoma.Frontiers in oncology
Diagnostic and triage performance of CDO1 and CELF4 methylation in cervical exfoliated cells compared with serum biomarkers for endometrial cancer in abnormal bleeding women.Journal of gynecologic oncology
Self-collected first-void urine cytology as a non-invasive triage tool for endometrial cancer detection.Frontiers in oncology
RPL22 mutation is a favourable prognostic subset within mismatch repair-deficient endometrial cancer: a retrospective cohort study.Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
Whole-tumor histogram analysis of non-Gaussian diffusion MRI models combined with clinicopathological indicators for assessing lymph node metastasis in endometrial cancer.Frontiers in medicine
Integrative bioinformatics and preliminary experimental validation suggest the therapeutic potential of lycorine in uterine corpus endometrial carcinoma.BMC complementary medicine and therapies
Treg and immune proliferative programs characterize anti-PD-1-responsive endometrial cancer: an integrative single-cell, spatial transcriptomic, and TCGA-UCEC reanalysis.Frontiers in genetics
Eicosapentaenoic acid exhibits antitumor effects and synergistically enhances carboplatin sensitivity in endometrial cancer.Frontiers in pharmacology